aluminium brands
68 registered brands containing aluminium in Kenya.
aluminium
PubChem CID 5359268Molecular formula: Al
Aluminum Acetate is an astringent. An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application. The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied. Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete's foot. Excessive dietary aluminum has been proposed to be a factor contributing to several neurological disorders in humans. Six 8-week-old female Swiss Webster mice were fed for 10 wk purified diets containing 100 (control), 500 or 1000 ug aluminum/g diet. Brain and liver lipid peroxidation was determined by evaluating the production of 2-thiobarbituric acid reactive substances in brain and liver homogenates in the presence or absence of 50 uM ferrous iron. 2-Thiobarbituric acid reactive substances production in the absence of iron in brain homogenates from mice fed the 1000 ug/g diet was higher (30%) than that in the 100 ug/g control group (3.1 vs 2.4 nmol 2-thiobarbituric acid reactive substances/mg protein). The addition of ferrous iron increased 2-thiobarbituric acid reactive substances production in brain homogenates from all 3 dietary groups. The iron induced 2-thiobarbituric acid reactive substances production was 26% higher in the 1000 ug/g brain homogenates than in the 100 ug/g group (4.9 vs 3.9 nmol 2-thiobarbituric acid reactive substances/mg protein). Brain 2-thiobarbituric acid reactive substances production in the presence and absence of iron was similar between the 100 and 500 ug/g aluminum groups. 2-Thiobarbituric acid reactive substances production in liver homogenates measured either with or without iron was similar for the 3 groups. These results show that, in mice, dietary aluminum intoxication leads to increased brain 2-thiobarbituric acid reactive substance production, suggesting that enhanced lipid peroxidation may be one possible mechanism underlying the neurological damage associated with increased tissue aluminum. Evidence is presented indicating that dementias are associated with a relative insufficiency of magnesium in the brain. Such insufficiency may be attributable to low intake or retention of magnesium; high intake of a neurotoxic metal, such as aluminum, which inhibits activity of magnesium requiring enzymes; or impaired transport of magnesium and/or enhanced transport of the neurotoxic metal into brain tissue. It is proposed that Alzheimer's disease involves a defective transport process, characterized by both an abnormally high incorporation of aluminum and an abnormally low incorporation that an altered serum protein contributes to the progression of Alzheimer's disease by having a greater affinity for aluminum than for magnesium, in contrast to the normal protein, which binds magnesium better than aluminum. The altered protein crosses the blood-brain barrier more efficiently than the normal protein and competes with the normal protein in binding to brain neurons. Binding of the altered protein to the target neurons would both facilitate aluminum uptake and impede magnesium uptake. Evidence suggests that albumin is the serum protein that is altered. Aluminum is established as a neurotoxin, although the basis for its toxicity is unknown. It recently has been shown to alter the function of the blood-brain barrier, which regulates ex
Source: PubChem (NCBI) ยท compound 5359268
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| PEPGEL ORAL SUSPENSION SEMITHICONE 25MG, MAGNESIUM HYDROXIDE USP 200MG, DRIED ALUMINIUM HYDROXIDE GEL USP 225MG |
Signature Healthcare | Registered | Kenya |
| PEPTICA GEL EACH 5 ML CONTAINS ALUMINIUM HYDROXIDE PASTE EQUIVALENT TO DRIED ALUMINIUM HYDROXIDE BP 225MG, MAGNESIUM HYDROXIDE PASTE EQUIVALENT TO MAGNESIUM HYDROXIDE BP 200MG AND SIMETHICONE USP 50MG |
Harleys | Registered | Kenya |
| PHARMACID SUSPENSION ALUMINIUM HYDROXIDE 120 MG MAGNESIUM TRISILICATE 250 MG PER 10ML |
Nairobi Enterprises | Registered | Kenya |
| POLYCID FORTE GEL ALUMINIUM HYDROXIDE GEL_ 300MG MAGNESIUM HYDROXIDE_..150MG SIMETHICONE_.125MG |
Globe Pharmacy | Registered | Kenya |
| POLYCID PLUS SUSPENSION EACH 5ML CONTAINS: DRIED ALUMINIUM HYDROXIDE 215MG MAGNESIUM HYDROXIDE 80MG SIMETHICONE 25MG |
Globe Pharmacy | Registered | Kenya |
| POLYCID PLUS TABLETS ALUMINIUM HYDROXIDE D-GEL 200MG+ MAGNESIUM HYDROXIDE 200MG + SIMETHICONE 25MG |
Globe Pharmacy | Registered | Kenya |
| PROOLAX SUSPENSION SIMETHICONE USP 50MMAGNESIUM HYDROXIDE USP 250 MGDRIED ALUMINIUM HYDROXIDE GEL USP 250MG |
Pro Med Pharmaceuticals | Registered | Kenya |
| RELCER GEL ALUMINIUM HYDROXIDE GEL USP E.Q TO ALUMINIUM HYDROXIDE 365 MG MAGNESIUM HYDROXIDE PASTE E.Q TO 80 MG MAGNESIUM HYDROXIDE SIMETHICONE USP 100 MG DEGLYCYRRHIZIANATED LIQUORICE E.Q TO LIQUORICE 400 MG |
Glenmark Pharmaceuticals | Registered | Kenya |
| RELCER GEL ALUMINIUM HYDROXIDE GEL USP E.Q TO ALUMINIUM HYDROXIDE 365 MG MAGNESIUM HYDROXIDE PASTE E.Q TO 80 MG MAGNESIUM HYDROXIDE SIMETHICONE USP 100 MG DEGLYCYRRHIZIANATED LIQUORICE E.Q TO LIQUORICE 400 MG |
Glenmark Pharmaceuticals Ltd | Registered | Kenya |
| RELCER TABLETS ALUMINIUM HYDROXIDE GEL USP E.Q TO ALUMINIUM HYDROXIDE 365 MG MAGNESIUM HYDFROXIDE PASTE E.Q TO 80 MG MAGNESIUM HYDROXIDESIMETHICONE USP 100 MGDEGLYCYRRHIZIANTED LIQUORICE E.Q TO LIQUORICE 400 MG |
Glenmark Pharmaceuticals | Registered | Kenya |
| STOPACID SUSPENSION ALUMINIUM HYDROXIDE BP 120MG& MAGNESIUM TRISILICATE BP 250MG/5ML |
Dawa | - | Kenya |
| TRYACTIN SUSPENSION MAGNESIUM TRISILICATE 500MG AND DRIED ALUMINIUM HYDROXIDE GEL 250MG PER 5ML |
Laboratory & Allied | Registered | Kenya |
| TRYACTIN TABLETS MAGNESIUM TRISILICATE 250MG AND DRIED ALUMINIUM HYDROXIDE 120MG PER TABLET |
Laboratory & Allied | Registered | Kenya |
| TUMBOCID TABLETS 120MG/250MG RESPECTIVELY |
Cadila Pharmaceuticals | Registered | Kenya |
| ULGICID SUSPENSION (MINT; PINEAPPLE; CHERRY) EACH 15 ML CONTAINS: ALGINIC ACID BP 200 MG MAGNESIUM HYDROXIDE BP 250 MG DRIED ALUMINIUM HYDROXIDE BP 250 MG MAGNESIUM TRISILICATE BP 250 MG SIMETICONE BP 125 MG |
Wessex Pharmaceuticals | Registered | Kenya |
| ULGICID TABLETS EACH CHEWABLE TABLET CONTAINS: ALGINIC ACID BP 200 MG MAGNESIUM HYDROXIDE BP 250 MG DRIED ALUMINIUM HYDROXIDE BP 250 MG MAGNESIUM TRISILICATE BP 250 MG SIMETICONE BP 125 MG |
Pharma Specialities | Registered | Kenya |
| UNICID SUSPENSION ALUMINIUM HYDROXIDE GEL 6GM MAGNESIUM HYDROXIDE BP 80 MG METHYL POLYSILOXANE USP 100MG LIQUORICE BP 400MG |
Nairobi Enterprises | Registered | Kenya |
| ZEECID TABLETS DRIED ALUMINIUM HYDROXIDE BP 120MG MAGNESIUM TRISILICATE BP 250MG |
Syner-med Pharmaceuticalsltd | Registered | Kenya |